Bibliography
- Biomarker Definitions Working Group: Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin. Pharmacol. Ther.69(3) , 89–95 (2001).
- De Gruttola VG , ClaxP, DeMetsDL et al.: Considerations in the evaluation of surrogate endpoints in clinical trials. summary of a National Institutes of Health workshop.Control. Clin. Trials22(5) , 485–502 (2001).